Treatment & Procedure
Our sacral neuromodulation (SNM) treatment services and clinical assessment information cover patient assessment, test stimulation, permanent implantation, device configuration options, and remote follow-up for selected patients with bladder and bowel dysfunction.
A key part of the treatment process is the two-stage approach: patients first undergo test stimulation for approximately two weeks, and permanent implantation is considered when symptom improvement reaches 50% or more.
-
SNM Post-Procedure Care And Follow-Up
After SNM implantation, patients can continue receiving support after returning to their home countries. Our service includes remote SNM device programming, post-procedure follow-up, annual
-
Permanent SNM Implantation Procedure
Permanent sacral neuromodulation (SNM) implantation is considered after a successful trial stimulation phase. Patients achieving at least 50% symptom improvement during Stage 1 may proceed to Stage 2
-
Temporary Sacral Neuromodulation Testing
Temporary Sacral Neuromodulation Testing allows patients to evaluate their response to sacral nerve stimulation before considering permanent implantation.
-
Sacral Nerve Stimulation Trial Phase
The Sacral Nerve Stimulation Trial Phase allows patients to evaluate symptom improvement before proceeding to permanent implantation. This sacral nerve stimulation trial procedure generally lasts
-
SNM Pre-Procedure Consultation
Our SNM pre-procedure consultation begins with a remote review of your medical records. By submitting available imaging, urodynamic studies, and physician notes, you can receive a preliminary
-
Sacral Neuromodulation Treatment Process
The sacral neuromodulation (SNM) treatment process follows a staged approach, beginning with pre-procedure assessment and temporary test stimulation before considering permanent implantation.
Sacral Neuromodulation Treatment Options
Our SNM-related treatment services address the following conditions:
- Refractory overactive bladder
- Neurogenic bladder
- Non-obstructive urinary retention
- Urgency urinary incontinence
- Fecal incontinence
- Refractory constipation
- Interstitial cystitis
- Chronic pelvic pain
SNM suitability depends on the patient's diagnosis, previous treatment history, clinical assessment, and response to test stimulation. These conditions do not automatically qualify every patient for implantation.
SNM Test Stimulation and Permanent Implantation
The treatment process consists of two stages: temporary test stimulation and permanent implantation.
| Treatment item | Procedure or condition |
|---|---|
| Electrode placement | Temporary electrode positioned near the sacral nerve |
| Guidance method | Fluoroscopy guidance |
| Anesthesia | Local anesthesia |
| Stimulation device | External pulse generator |
| Test period | Approximately 2 weeks |
| Response criterion | Symptom improvement of 50% or more |
| Next stage | Permanent implantation when the response criterion is met |
| Typical implantation time | Approximately 1 hour |
During test stimulation, the patient's symptoms are evaluated to determine whether the treatment provides sufficient improvement. Permanent implantation is considered only after the trial assessment.
The two-stage process allows the treatment decision to be based on the patient's actual response rather than proceeding directly to permanent implantation.
Neurogenic Bladder and Urinary Retention Assessment
SNM assessment covers selected patients with neurogenic bladder and non-obstructive urinary retention.
Relevant neurological conditions discussed in our treatment information include:
- Spinal cord injury
- Stroke
- Parkinson's disease
Patient assessment may include imaging examinations, urodynamic testing, and other diagnostic investigations according to the medical history and clinical requirements.
For urinary retention, distinguishing non-obstructive retention from obstruction-related conditions is important. Residual urine volume is also considered during assessment. The clinical information discusses patients whose residual urine volume frequently exceeds 100 mL, but this is not a universal SNM eligibility threshold.
SNM Device Configuration Options
Three sacral neuromodulation device configurations are listed in our SNM treatment information. Their battery types, stated service lives, weights, and charging requirements differ.
| Configuration | Battery type | Stated battery life | Weight | Capacity | Charging |
|---|---|---|---|---|---|
| G132 | Non-rechargeable | 6–8 years | 25 g | 1850 mAh | No regular charging |
| G131 | Non-rechargeable | 8–11 years | 35 g | 2500 mAh | No regular charging |
| G134R | Rechargeable | Over 20 years | 36 g | N/A | Wireless charging, approximately every 2–3 months |
Stimulation specifications
| Configuration | Stimulation range |
|---|---|
| G132 | 0–10 V / 0–25 mA |
| G131 | 0–10 V / 0–25 mA |
| G134R | 0–10 V / 0–25 mA |
The published device information lists 1.5T and 3.0T MRI support for all three configurations. Actual MRI eligibility and scanning conditions must be verified against the applicable device instructions.
The main configuration difference is battery management. G132 and G131 use non-rechargeable batteries, while G134R has a rechargeable battery with wireless charging. This distinction is relevant when discussing long-term device management with the treating specialist.
Remote SNM Programming and Follow-Up
Remote sacral neuromodulation programming is included in the treatment support information for international patients returning to their home countries after implantation.
Stimulation parameters can be adjusted remotely, allowing patients to receive programming support without travelling back to China solely for routine parameter adjustments.
The available programming arrangements depend on the implanted device and the patient's clinical circumstances.
Specialist Assessment and International Patient Support
The medical specialist profile presented on our website describes more than 30 years of urological clinical experience and over 1,000 SNM procedures. The profile also identifies the specialist as a deputy chief physician in urology and a leader in urinary continence-related clinical work.
For international patients seeking an assessment before travelling, remote second-opinion services are available.
The assessment process includes:
- Submit existing medical records, imaging reports, urodynamic results, and previous treatment information.
- The medical team reviews the submitted records.
- A written remote assessment is provided within 1–3 working days.
- If the available information is insufficient, further clinical evaluation in China may be recommended.
The remote second-opinion service is described as free of charge.
Request an SNM Treatment Assessment
If you are considering sacral neuromodulation for neurogenic bladder, non-obstructive urinary retention, or another relevant condition, you can begin by submitting your existing medical records.
Send us your available imaging reports, urodynamic results, and previous treatment details to request a remote second opinion. The assessment can help determine whether SNM may be appropriate and whether further clinical evaluation is needed.
Dr. Zhang Yifei has been engaged in clinical practice for more than 30 years and he is an Associate Chief Physician in the Department of Urology. If you're going to know the cost of treatment & procedure, welcome to contact us for pricelist and quotation.
Decrease in pelvic pain severity, implantable pulse generator, sacral stimulation pulse generator